ArticleDrug design, development and therapy2015

Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.

Tao Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.